OSPREY MEDICAL INC - Announcements

0.00%

20.0¢

Currently unlisted.

Osprey Medical, Inc. is a commercial stage company, which is focused on protecting... Osprey Medical, Inc. is a commercial stage company, which is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. The Company’s products include AVERT, AVERT Plus, the DyeVert NG, DyeVert Plus, and DyeVert Plus EZ Systems. The AVERT Plus System reduces and monitors the amount of contrast dye used in commonly performed heart and peripheral vascular procedures. The DyeVert System is a self-adjusting product that reduces the amount of contrast dye used in commonly performed heart and peripheral procedures. DyeVert interfaces with syringe-manifold systems. These technologies are available with the United States Food and Drug Administration cleared indication for dye volume reduction. Its dye reduction and monitoring technologies are designed to help physicians minimize dye usage and reduce kidney damage associated with the use of contrast media for common cardiovascular procedures.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

OSP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	425.63KB	Share
OSP	Business Restructure	PRICE SENSITIVE	01/06/22	166.44KB	Share
OSP	Update from Osprey	PRICE SENSITIVE	06/05/22	161.1KB	Share
OSP	Voluntary Suspension	PRICE SENSITIVE	03/05/22	237.28KB	Share
OSP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	461.57KB	Share
OSP	Trading Halt	PRICE SENSITIVE	29/04/22	228.87KB	Share
OSP	Osprey Medical Financial Results for FY2021	PRICE SENSITIVE	28/02/22	210.3KB	Share
OSP	Appendix 4E and FY2021 Consolidated Financial Statements	PRICE SENSITIVE	28/02/22	505.33KB	Share
OSP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	506.48KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	20/10/21	471.59KB	Share
OSP	Notice of Special Meeting of Stockholders	PRICE SENSITIVE	20/08/21	573.04KB	Share
OSP	Global expansion strategy progress strengthens revenues	PRICE SENSITIVE	17/08/21	298.84KB	Share
OSP	Appendix 4D Half Year Report & Accounts	PRICE SENSITIVE	17/08/21	466.8KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	29/07/21	536.51KB	Share
OSP	Canadian Expansion and exclusive GE distribution agreement	PRICE SENSITIVE	20/07/21	261.52KB	Share
OSP	Appendix 4C and Business Update	PRICE SENSITIVE	22/04/21	618.78KB	Share
OSP	Osprey Medical Releases FY20 Financial Results	PRICE SENSITIVE	26/02/21	249.81KB	Share
OSP	Appendix 4E and FY20 Consolidated Financial Statements	PRICE SENSITIVE	26/02/21	529.07KB	Share
OSP	Funding Update - Exercise of Options and PPP Loan	PRICE SENSITIVE	23/02/21	180.68KB	Share
OSP	Appendix 4C and Business Update	PRICE SENSITIVE	28/01/21	537.08KB	Share
OSP	Osprey Investor Presentation	PRICE SENSITIVE	03/12/20	1.86MB	Share
OSP	Strategic sales agency agreement signed for new US region	PRICE SENSITIVE	26/11/20	288.47KB	Share
OSP	Strong quarter with milestone distribution agreements signed	PRICE SENSITIVE	29/10/20	528.78KB	Share
OSP	Osprey receives Supplier Horizon Award from Premier Inc	PRICE SENSITIVE	29/09/20	238.51KB	Share
OSP	RHCG to distribute Osprey technology across Australia and NZ	PRICE SENSITIVE	24/09/20	261.09KB	Share
OSP	Osprey to Present at HC Wainwright Annual Global Conference	PRICE SENSITIVE	15/09/20	11.86MB	Share
OSP	Positive outlook following adjustments to COVID-19	PRICE SENSITIVE	25/08/20	314.27KB	Share
OSP	Appendix 4D Half Year Report & Accounts	PRICE SENSITIVE	25/08/20	471.82KB	Share
OSP	CE Marking received for core European product	PRICE SENSITIVE	13/08/20	311.98KB	Share
OSP	GE Healthcare to Distribute Osprey Medical Technology	PRICE SENSITIVE	30/07/20	257.44KB	Share
OSP	Appendix 4C - Quarterly Report	PRICE SENSITIVE	28/07/20	535.73KB	Share
OSP	Update on Shortfall Placement and Quarterly Results Release	PRICE SENSITIVE	15/07/20	226.77KB	Share
OSP	Response to ASX Price Query	PRICE SENSITIVE	03/07/20	302.94KB	Share
OSP	Chairman's Address and CEO's Presentation at Annual Meeting	PRICE SENSITIVE	19/06/20	10.88MB	Share
OSP	Issue of Securities under Shortfall Placement	PRICE SENSITIVE	12/06/20	175.9KB	Share
OSP	Osprey raises an additional $2.6m under Shortfall Placement	PRICE SENSITIVE	09/06/20	179.11KB	Share
OSP	Trading Halt	PRICE SENSITIVE	04/06/20	364.57KB	Share
OSP	DyeVert featured at the SCAI 2020 Scientific Session	PRICE SENSITIVE	28/05/20	219.86KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	30/04/20	253.25KB	Share
OSP	Completion of Entitlement Offer	PRICE SENSITIVE	29/04/20	182.26KB	Share
OSP	Osprey Medical secures US Government COVID-19 Relief Loan	PRICE SENSITIVE	29/04/20	174.72KB	Share
OSP	Osprey Medical Prospectus	PRICE SENSITIVE	03/04/20	467.68KB	Share
OSP	Osprey Medical Announces Capital Raising and Trading Update	PRICE SENSITIVE	03/04/20	126.46KB	Share
OSP	Trading Halt	PRICE SENSITIVE	01/04/20	353.66KB	Share
OSP	Osprey Medical Releases FY19 Financial Results	PRICE SENSITIVE	25/02/20	221.81KB	Share
OSP	Appendix 4E and FY19 Consolidated Financial Statements	PRICE SENSITIVE	25/02/20	549.96KB	Share
OSP	NICE Issues Positive MedTech Innovation Briefing on DyeVert	PRICE SENSITIVE	10/02/20	228.64KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	31/01/20	499.23KB	Share
OSP	Osprey Fourth Quater Update	PRICE SENSITIVE	20/12/19	223KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	29/10/19	459.36KB	Share
OSP	Contrast-Induced AKI Prevention Strategies Featured at TCT	PRICE SENSITIVE	03/10/19	277.67KB	Share
OSP	Osprey CEO Presentation at ASX Small & Mid Cap Conference	PRICE SENSITIVE	05/09/19	2.72MB	Share
OSP	First Half Revenues Increase 54% to US$1.8 Million	PRICE SENSITIVE	14/08/19	306.29KB	Share
OSP	Appendix 4D Half Year Report & Accounts	PRICE SENSITIVE	14/08/19	621.69KB	Share
OSP	64% Increase in DyeVert Second Quarter Unit Sales	PRICE SENSITIVE	15/07/19	261.95KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	15/07/19	169.32KB	Share
OSP	US Government to Transform Kidney Care	PRICE SENSITIVE	12/07/19	277KB	Share
OSP	Osprey to Deliver AKI Burden of Illness Data to Premier Inc	PRICE SENSITIVE	13/06/19	209.24KB	Share
OSP	Chairman's Address and CEO's Presentation at Annual Meeting	PRICE SENSITIVE	09/05/19	11.97MB	Share
OSP	73% Increase in DyeVert First Quarter Unit Sales	PRICE SENSITIVE	16/04/19	318.55KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	16/04/19	168.97KB	Share
OSP	Investor Presentation	PRICE SENSITIVE	04/03/19	5.96MB	Share
OSP	Preliminary Final Report and Consolidated Financial Accounts	PRICE SENSITIVE	26/02/19	879.5KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	29/01/19	438.39KB	Share
OSP	Osprey awarded a group purchasing agreement with Premier	PRICE SENSITIVE	03/12/18	272.28KB	Share
OSP	Completion of Entitlement Offer	PRICE SENSITIVE	28/11/18	291.17KB	Share
OSP	Entitlement Offer - Update on shortfall	PRICE SENSITIVE	19/11/18	289.41KB	Share
OSP	Extension of Closing Date of Entitlement Offer	PRICE SENSITIVE	13/11/18	301.2KB	Share
OSP	Completion of Private Placement	PRICE SENSITIVE	06/11/18	293.31KB	Share
OSP	Entitlement Offer Booklet	PRICE SENSITIVE	30/10/18	301.01KB	Share
OSP	Investor Presentation	PRICE SENSITIVE	30/10/18	2.59MB	Share
OSP	Appendix 4C	PRICE SENSITIVE	30/10/18	765.39KB	Share
OSP	Capital raising to accelerate GPO focused growth strategy	PRICE SENSITIVE	30/10/18	376.73KB	Share
OSP	Trading Halt	PRICE SENSITIVE	29/10/18	470.26KB	Share
OSP	Osprey and GE Healthcare Launch New Educational Program	PRICE SENSITIVE	20/09/18	392.23KB	Share
OSP	Osprey Medical begins market access process in UK	PRICE SENSITIVE	07/09/18	241.17KB	Share
OSP	Half Yearly Accounts Report	PRICE SENSITIVE	27/08/18	333.46KB	Share
OSP	Appendix 4D Half Year Report & Accounts	PRICE SENSITIVE	27/08/18	549.59KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	19/07/18	1.06MB	Share
OSP	Chairman's Address and CEO's Presentation at Annual Meeting	PRICE SENSITIVE	10/05/18	10.14MB	Share
OSP	Strong recovery for DyeVert Plus in April 2018	PRICE SENSITIVE	02/05/18	95.67KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	26/04/18	1.77MB	Share
OSP	Preliminary Final Report and Consolidated Financial Accounts	PRICE SENSITIVE	26/02/18	470.03KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	24/01/18	1.93MB	Share
OSP	Appendix 4C	PRICE SENSITIVE	16/10/17	1.41MB	Share
OSP	Successful completion of A$10.3 million entitlement offer	PRICE SENSITIVE	30/08/17	114.27KB	Share
OSP	Appendix 4D Half Year Report & Accounts	PRICE SENSITIVE	21/08/17	207.47KB	Share
OSP	Private Placement Update	PRICE SENSITIVE	11/08/17	97.6KB	Share
OSP	Entitlement Offer Booklet	PRICE SENSITIVE	04/08/17	372.17KB	Share
OSP	Over-subscribed placement and underwritten entitlement offer	PRICE SENSITIVE	04/08/17	145.92KB	Share
OSP	Trading Halt	PRICE SENSITIVE	02/08/17	333.8KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	13/07/17	1.31MB	Share
OSP	Osprey Medical Increases Addressable Market	PRICE SENSITIVE	03/07/17	1.16MB	Share
OSP	Appendix 4C	PRICE SENSITIVE	18/04/17	1.54MB	Share
OSP	Osprey Medical Receives US FDA Clearance for DyeVert PLUS	PRICE SENSITIVE	09/03/17	371.4KB	Share
OSP	Preliminary Final Report and Consolidated Financial Accounts	PRICE SENSITIVE	27/02/17	295.79KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	30/01/17	1.62MB	Share
OSP	Osprey Introduces DyeVert PLUS at TCT-OSP.AX	PRICE SENSITIVE	02/11/16	370.42KB	Share
OSP	Appendix 4C-OSP.AX	PRICE SENSITIVE	14/10/16	1.58MB	Share
OSP	Appendix 4D Half Year Report & Accounts-OSP.AX	PRICE SENSITIVE	29/08/16	198.66KB	Share

OSP Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	425.63KB	Share
OSP Business Restructure
01/06/22	PRICE SENSITIVE	166.44KB	Share
OSP Update from Osprey
06/05/22	PRICE SENSITIVE	161.1KB	Share
OSP Voluntary Suspension
03/05/22	PRICE SENSITIVE	237.28KB	Share
OSP Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	461.57KB	Share
OSP Trading Halt
29/04/22	PRICE SENSITIVE	228.87KB	Share
OSP Osprey Medical Financial Results for FY2021
28/02/22	PRICE SENSITIVE	210.3KB	Share
OSP Appendix 4E and FY2021 Consolidated Financial Statements
28/02/22	PRICE SENSITIVE	505.33KB	Share
OSP Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	506.48KB	Share
OSP Appendix 4C
20/10/21	PRICE SENSITIVE	471.59KB	Share
OSP Notice of Special Meeting of Stockholders
20/08/21	PRICE SENSITIVE	573.04KB	Share
OSP Global expansion strategy progress strengthens revenues
17/08/21	PRICE SENSITIVE	298.84KB	Share
OSP Appendix 4D Half Year Report & Accounts
17/08/21	PRICE SENSITIVE	466.8KB	Share
OSP Appendix 4C
29/07/21	PRICE SENSITIVE	536.51KB	Share
OSP Canadian Expansion and exclusive GE distribution agreement
20/07/21	PRICE SENSITIVE	261.52KB	Share
OSP Appendix 4C and Business Update
22/04/21	PRICE SENSITIVE	618.78KB	Share
OSP Osprey Medical Releases FY20 Financial Results
26/02/21	PRICE SENSITIVE	249.81KB	Share
OSP Appendix 4E and FY20 Consolidated Financial Statements
26/02/21	PRICE SENSITIVE	529.07KB	Share
OSP Funding Update - Exercise of Options and PPP Loan
23/02/21	PRICE SENSITIVE	180.68KB	Share
OSP Appendix 4C and Business Update
28/01/21	PRICE SENSITIVE	537.08KB	Share
OSP Osprey Investor Presentation
03/12/20	PRICE SENSITIVE	1.86MB	Share
OSP Strategic sales agency agreement signed for new US region
26/11/20	PRICE SENSITIVE	288.47KB	Share
OSP Strong quarter with milestone distribution agreements signed
29/10/20	PRICE SENSITIVE	528.78KB	Share
OSP Osprey receives Supplier Horizon Award from Premier Inc
29/09/20	PRICE SENSITIVE	238.51KB	Share
OSP RHCG to distribute Osprey technology across Australia and NZ
24/09/20	PRICE SENSITIVE	261.09KB	Share
OSP Osprey to Present at HC Wainwright Annual Global Conference
15/09/20	PRICE SENSITIVE	11.86MB	Share
OSP Positive outlook following adjustments to COVID-19
25/08/20	PRICE SENSITIVE	314.27KB	Share
OSP Appendix 4D Half Year Report & Accounts
25/08/20	PRICE SENSITIVE	471.82KB	Share
OSP CE Marking received for core European product
13/08/20	PRICE SENSITIVE	311.98KB	Share
OSP GE Healthcare to Distribute Osprey Medical Technology
30/07/20	PRICE SENSITIVE	257.44KB	Share
OSP Appendix 4C - Quarterly Report
28/07/20	PRICE SENSITIVE	535.73KB	Share
OSP Update on Shortfall Placement and Quarterly Results Release
15/07/20	PRICE SENSITIVE	226.77KB	Share
OSP Response to ASX Price Query
03/07/20	PRICE SENSITIVE	302.94KB	Share
OSP Chairman's Address and CEO's Presentation at Annual Meeting
19/06/20	PRICE SENSITIVE	10.88MB	Share
OSP Issue of Securities under Shortfall Placement
12/06/20	PRICE SENSITIVE	175.9KB	Share
OSP Osprey raises an additional $2.6m under Shortfall Placement
09/06/20	PRICE SENSITIVE	179.11KB	Share
OSP Trading Halt
04/06/20	PRICE SENSITIVE	364.57KB	Share
OSP DyeVert featured at the SCAI 2020 Scientific Session
28/05/20	PRICE SENSITIVE	219.86KB	Share
OSP Appendix 4C
30/04/20	PRICE SENSITIVE	253.25KB	Share
OSP Completion of Entitlement Offer
29/04/20	PRICE SENSITIVE	182.26KB	Share
OSP Osprey Medical secures US Government COVID-19 Relief Loan
29/04/20	PRICE SENSITIVE	174.72KB	Share
OSP Osprey Medical Prospectus
03/04/20	PRICE SENSITIVE	467.68KB	Share
OSP Osprey Medical Announces Capital Raising and Trading Update
03/04/20	PRICE SENSITIVE	126.46KB	Share
OSP Trading Halt
01/04/20	PRICE SENSITIVE	353.66KB	Share
OSP Osprey Medical Releases FY19 Financial Results
25/02/20	PRICE SENSITIVE	221.81KB	Share
OSP Appendix 4E and FY19 Consolidated Financial Statements
25/02/20	PRICE SENSITIVE	549.96KB	Share
OSP NICE Issues Positive MedTech Innovation Briefing on DyeVert
10/02/20	PRICE SENSITIVE	228.64KB	Share
OSP Appendix 4C
31/01/20	PRICE SENSITIVE	499.23KB	Share
OSP Osprey Fourth Quater Update
20/12/19	PRICE SENSITIVE	223KB	Share
OSP Appendix 4C
29/10/19	PRICE SENSITIVE	459.36KB	Share
OSP Contrast-Induced AKI Prevention Strategies Featured at TCT
03/10/19	PRICE SENSITIVE	277.67KB	Share
OSP Osprey CEO Presentation at ASX Small & Mid Cap Conference
05/09/19	PRICE SENSITIVE	2.72MB	Share
OSP First Half Revenues Increase 54% to US$1.8 Million
14/08/19	PRICE SENSITIVE	306.29KB	Share
OSP Appendix 4D Half Year Report & Accounts
14/08/19	PRICE SENSITIVE	621.69KB	Share
OSP 64% Increase in DyeVert Second Quarter Unit Sales
15/07/19	PRICE SENSITIVE	261.95KB	Share
OSP Appendix 4C
15/07/19	PRICE SENSITIVE	169.32KB	Share
OSP US Government to Transform Kidney Care
12/07/19	PRICE SENSITIVE	277KB	Share
OSP Osprey to Deliver AKI Burden of Illness Data to Premier Inc
13/06/19	PRICE SENSITIVE	209.24KB	Share
OSP Chairman's Address and CEO's Presentation at Annual Meeting
09/05/19	PRICE SENSITIVE	11.97MB	Share
OSP 73% Increase in DyeVert First Quarter Unit Sales
16/04/19	PRICE SENSITIVE	318.55KB	Share
OSP Appendix 4C
16/04/19	PRICE SENSITIVE	168.97KB	Share
OSP Investor Presentation
04/03/19	PRICE SENSITIVE	5.96MB	Share
OSP Preliminary Final Report and Consolidated Financial Accounts
26/02/19	PRICE SENSITIVE	879.5KB	Share
OSP Appendix 4C
29/01/19	PRICE SENSITIVE	438.39KB	Share
OSP Osprey awarded a group purchasing agreement with Premier
03/12/18	PRICE SENSITIVE	272.28KB	Share
OSP Completion of Entitlement Offer
28/11/18	PRICE SENSITIVE	291.17KB	Share
OSP Entitlement Offer - Update on shortfall
19/11/18	PRICE SENSITIVE	289.41KB	Share
OSP Extension of Closing Date of Entitlement Offer
13/11/18	PRICE SENSITIVE	301.2KB	Share
OSP Completion of Private Placement
06/11/18	PRICE SENSITIVE	293.31KB	Share
OSP Entitlement Offer Booklet
30/10/18	PRICE SENSITIVE	301.01KB	Share
OSP Investor Presentation
30/10/18	PRICE SENSITIVE	2.59MB	Share
OSP Appendix 4C
30/10/18	PRICE SENSITIVE	765.39KB	Share
OSP Capital raising to accelerate GPO focused growth strategy
30/10/18	PRICE SENSITIVE	376.73KB	Share
OSP Trading Halt
29/10/18	PRICE SENSITIVE	470.26KB	Share
OSP Osprey and GE Healthcare Launch New Educational Program
20/09/18	PRICE SENSITIVE	392.23KB	Share
OSP Osprey Medical begins market access process in UK
07/09/18	PRICE SENSITIVE	241.17KB	Share
OSP Half Yearly Accounts Report
27/08/18	PRICE SENSITIVE	333.46KB	Share
OSP Appendix 4D Half Year Report & Accounts
27/08/18	PRICE SENSITIVE	549.59KB	Share
OSP Appendix 4C
19/07/18	PRICE SENSITIVE	1.06MB	Share
OSP Chairman's Address and CEO's Presentation at Annual Meeting
10/05/18	PRICE SENSITIVE	10.14MB	Share
OSP Strong recovery for DyeVert Plus in April 2018
02/05/18	PRICE SENSITIVE	95.67KB	Share
OSP Appendix 4C
26/04/18	PRICE SENSITIVE	1.77MB	Share
OSP Preliminary Final Report and Consolidated Financial Accounts
26/02/18	PRICE SENSITIVE	470.03KB	Share
OSP Appendix 4C
24/01/18	PRICE SENSITIVE	1.93MB	Share
OSP Appendix 4C
16/10/17	PRICE SENSITIVE	1.41MB	Share
OSP Successful completion of A$10.3 million entitlement offer
30/08/17	PRICE SENSITIVE	114.27KB	Share
OSP Appendix 4D Half Year Report & Accounts
21/08/17	PRICE SENSITIVE	207.47KB	Share
OSP Private Placement Update
11/08/17	PRICE SENSITIVE	97.6KB	Share
OSP Entitlement Offer Booklet
04/08/17	PRICE SENSITIVE	372.17KB	Share
OSP Over-subscribed placement and underwritten entitlement offer
04/08/17	PRICE SENSITIVE	145.92KB	Share
OSP Trading Halt
02/08/17	PRICE SENSITIVE	333.8KB	Share
OSP Appendix 4C
13/07/17	PRICE SENSITIVE	1.31MB	Share
OSP Osprey Medical Increases Addressable Market
03/07/17	PRICE SENSITIVE	1.16MB	Share
OSP Appendix 4C
18/04/17	PRICE SENSITIVE	1.54MB	Share
OSP Osprey Medical Receives US FDA Clearance for DyeVert PLUS
09/03/17	PRICE SENSITIVE	371.4KB	Share
OSP Preliminary Final Report and Consolidated Financial Accounts
27/02/17	PRICE SENSITIVE	295.79KB	Share
OSP Appendix 4C
30/01/17	PRICE SENSITIVE	1.62MB	Share
OSP Osprey Introduces DyeVert PLUS at TCT-OSP.AX
02/11/16	PRICE SENSITIVE	370.42KB	Share
OSP Appendix 4C-OSP.AX
14/10/16	PRICE SENSITIVE	1.58MB	Share
OSP Appendix 4D Half Year Report & Accounts-OSP.AX
29/08/16	PRICE SENSITIVE	198.66KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.